Interestingly, the GFP-modified Foxp3 was protective in a model of arthritis due to disruption in HIF1α binding and increasing Foxp3 interactions with Interferon Regulatory Factor 4 (IRF4) leading to improved Treg control of Th2 and Th17 responses (31). This evidence concerns the gene FOXP3 and arthritic joint disease.